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Human viral infections such as HIV and EBV typically evoke a strong and diverse CD8 T cell response. Relatively little is
known about the extent to which TCR repertoire evolution occurs during viral infection or how repertoire evolution affects the
efficacy of the CD8 T cell response. In this study we describe a general approach for tracking TCR repertoire evolution
during viral infection. IFN surface capture and MHC class I tetramer staining were independently used to isolate
EBV-specific CD8 T cells from peripheral blood. Anchored RT-PCR and clonotype TCR repertoire analysis were performed
immediately after isolating the cells. We find that the TCR repertoires of the IFN-secreting and MHC class I tetramer staining
populations were similar. In one subject a detailed analysis of the TCR repertoire during the first year of EBV infection was
performed and over 600 TCR sequences targeting an EBV-immunodominant epitope were analyzed. Although some
repertoire evolution occurred during the year, in general, the degree of repertoire drift was small. TCR repertoire analysis for
an HIV-immunodominant epitope revealed a highly conserved amino acid motif in the D region of TCR that recognizes the
epitope and suggested that T cell precursor frequency influences which epitopes are targeted early in HIV infection. This
methodology, which allows one to sort antigen-specific T cells based on different functional assays and to obtain a snapshot
of their TCR repertoire with relative ease, should lead to a richer understanding of the rules underlying antigen recognitionKey Words: T cell receptors; HIV; EBV; CTL.
INTRODUCTION
The ability of the T cell immune system to recognize a
vast array of pathogens rests on the diversity of T cell
receptors displayed on naive T cells. Upon virus infec-
tion, antigen-specific naive T cells become activated,
proliferate, and differentiate into memory T cells (Ahmed
and Gray, 1996; Lanzavecchia and Sallusto, 2000). Mem-
ory T cells that persist following viral challenge are a
heterogeneous population, differing in their TCR, their
gene expression profiles, their homing patterns, and
their functional capabilities, such as the ability to secrete
cytokines and to mediate antigen-specific cytolysis
(Butcher and Picker, 1996; Naumov et al., 1998; Zajac et
al., 1998; Tan et al., 1999; Appay et al., 2000; Champagne
et al., 2001; Hislop et al., 2001; Welsh, 2001; McKay et al.,
2002). Memory T cells are also a dynamic population
whose functions and constituents evolve over time
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474(McHeyzer-Williams and Davis, 1995; Busch et al., 1998;
Annels et al., 2000; Vogel et al., 2001; Douek et al., 2002).
Presently, relatively little is known about the degree to
which T cell evolution occurs during viral infection, why
it occurs, and how it impacts the ability of the immune
system to control a viral infection.
The diversity of TCR gene sequences, besides en-
abling for differential antigen recognition, provides a
unique label for tracking T cell responses. TCR diversity
is generated by combinatorial associations of germline
V(D)J regions. Additional TCR sequence diversity results
from imprecise joining and random addition and deletion
of nucleotide bases at V(D)J splice junctures (in a pro-
cess called N-diversification).
In this study we isolated virus-specific T cells based
on MHC class I tetramer staining (Altman et al., 1996) or
IFN secretion (Manz et al., 1995; Brosterhus et al., 1999)
and used anchor RT-PCR to derive and detail the evolu-
tion of the TCR repertoire during Epstein–Barr virus (EBV)
and human immunodeficiency virus (HIV) infection. This
methodology, which isolates antigen-specific T cells
based on different functional assays, provides a general
approach for clonal analysis of polyclonal T cell re-
sponses and permits a finer appreciation of the rulesand T cell evolution during viral infection. © 2002 Elsevier Sc
ment of Immunology, Harvard Medical School, 1 Pine Hill Drive, South-
borough, MA 01772. E-mail: gcohen@hms.harvard.edu.
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underlying antigen recognition and driving T cell evolu-
tion during viral infection.ience (US
RESULTS
TCR repertoire analysis of EBV-specific CD8 T cells
The IFN capture assay allows for the isolation of
viable antigen-specific T cells (Manz et al., 1995; Broster-
hus et al., 1999). Figure 1 shows typical results using the
IFN capture assay. Peripheral blood mononuclear cells
(PBMC) from a healthy, chronic EBV individual, subject
E1, were stimulated with a peptide, GLCTLVAML, derived
from the EBV lytic cycle protein BMLF1 (designated EBV
peptide GL9). GL9 is an immunodominant epitope in
HLA-A2 individuals (Annels et al., 2000). In this subject,
0.7% of the CD8 T cells produced IFN in response to
the peptide (Fig. 1A). In contrast, a control HLA-A2 re-
stricted peptide, SL9, derived from the HIV-1 Gag protein
(Johnson et al., 1991) elicited a 0.01% response (Fig. 1C).
Magnetic sorting for surface-captured IFN enriched the
IFN population approximately 100-fold (compare Figs.
1A and 1B). Fluorescence-activated cell sorting was then
used to further purify the live IFN CD8 T cell popu-
lation for TCR repertoire analysis to greater than 98%
purity (data not shown).
Table 1, column A, lists TCR amino acid sequences
obtained from the GL9-specific IFN CD8 T cell pop-
ulation for subject E1. Although this T cell population
contained many different TCR sequences, the repertoire
was dominated by a few sequences, and three se-
quences account for over 40% of the repertoire (e.g.,
V1.1–J1.1-SGQLT comprise 17% of the TCR sequences).
Six weeks later the TCR repertoire analysis for this sub-
ject was repeated (Table 1, column B). For this second
TCR analysis, because less blood was drawn and be-
cause of a decline in E1’s IFN response (from 0.7% of
CD8 T cells to 0.2%), only 5000 GL9-specific T cells
were isolated (vs 75,000 for the first time point). Never-
theless, the dominant TCR sequences (sequences that
account for greater than 10% of the repertoire) present
earlier were still present at the second time point. Dif-
ferences between these two repertoires may reflect the
limited number of TCR sequenced, random variations
inherent to the RT-PCR TCR assay, or real fluctuations in
the in vivo repertoire over time (see below).
To confirm that the IFN/TCR repertoire assay was
generating data reflective of in vivo TCR frequencies, we
compared the V distribution of the IFN sequenced
cells (Table 1) to that of PBMC costained with an HLA-
A2/GL9 tetramer and a panel of 15 V antibodies. Figure
2 (top row) shows the V staining results for subject E1.
Eleven of the fifteen V antibodies stained no tetramer-
positive cells; V8 and V17 are shown as representa-
tive examples. The V distribution seen in the tet-
ramer/V staining populations and the V distribution
derived from TCR sequenced cells were in good agree-
ment. For example, in Fig. 2, for subject E1 (top row) the
frequencies of tetramer staining cells that were V1, V2,
V8, V16, V17, and V22 were 16, 20, 0, 7, 0, and 28%
and in the IFN/RT-PCR sequenced samples the fre-
quencies were 31, 15, 1, 3, 0, and 28%, respectively. For
the data in Fig. 2, the correlation between V percent-
ages determined by V staining and those determined
by TCR sequencing was highly significant (R  0.94, P 
6  109). However, the sequence analysis provided
much more detail regarding the clonality of the TCR
TABLE 1
Subject E1 GL9-Specific TCR Repertoire
Column: A B
Time (weeks): 0 6







V J V D-region J % %
1.1 1.1 CASS SGQLT NTE 17 28
1.1 2.1 CASS ASARP EQF 4 —
1.1 2.1 CASS SGLLTAD EQF — 3
1.1 2.2 CASS SGQVS NTG — 9
2.1 1.2 CSAR DRTGN GYT 4 —
2.1 2.5 CSAR GDGQGDLL QET 13 10
4.1 1.4 CSV GTGG TNE 6 9
4.1 1.4 CSV GSGG TNE 6 —
4.1 1.4 CSV GAGG TNE — 2
14.1 2.2 CAS SPDRLG TGE 4 —
16.1 2.4 CASSQ SPGGI IQY 4 —
18.1 2.2 CAS SSGQTLP GEL — 2
22.1 2.2 CAS SSQRKVP GEL 12 36
22.1 2.2 CAS FSQRKVP GEL 2 —
22.1 2.2 CAS SEVKVSP GEL 2 —
22.1 2.2 CAS SEGAVAP GEL — 2
Other single sequences: 27 0
Total sequenced: 52 58
a Single sequences are not shown unless they are similar to another
sequence in the repertoire.
FIG. 1. Magnetic bead purification of IFN secreting cells. PBMC
from subject E1 were stimulated with the GL9 peptide (A and B) or a
control peptide (C and D). Antigen-specific cells were isolated using
the INF capture assay. Flow cytometry was used to gate on the CD3
CD8 lymphocytes. Shown are the IFN (y-axis) and 7AAD (x-axis)
staining of the CD3 CD8 lymphocyte-gated population prior to mag-
netic bead purification (A and C) and postmagnetic bead purification (B
and D). Percentages shown refer to the IFN population. 7-amino-
actinomycin (7AAD) staining was used to distinguish live from dead
cells.
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repertoire than did the V staining analysis. The results
in Fig. 2 also indicated that the IFN capture assay and
tetramer staining methods identified cells that used a
similar repertoire of V chains.
Comparison of the TCR repertoire of IFN cells to
that of tetramer cells
The above studies suggested that one can use the
IFN capture to assess TCR repertoire of virus-specific
CD8 T cells. However, because of the low level of
IFN cells in subject E1, it became difficult to analyze
this subject’s TCR repertoire over time or to compare in
detail the repertoire of the IFN and tetramer-staining
populations. Therefore, two other subjects, E2 and E3,
with stronger EBV GL9 responses were studied. Subject
E2, similar to E1, was chronically infected with EBV. In
contrast, the analysis on subject E3 began when he
presented with acute infectious mononucleosis. Table 2
lists the TCR repertoire of GL9-specific T cells from
subject E2 isolated by the IFN capture assay (column A)
or by MHC tetramer staining (column B). These reper-
toires derive from PBMC isolated on the same day. On
the day of assay, subject E2’s IFN response was 2%
and his tetramer response was 6% of CD8 T cells
(data not shown). Despite this difference, the TCR rep-
ertoires of the two populations were highly similar and
94% of the tetramer-derived sequences appeared in the
IFN-derived repertoire.
For subject E3, Table 3, columns A–D, shows the TCR
repertoire over the initial 3 weeks of acute infection.
During this period his GL9 tetramer response fluctuated
between 4 and 10% and the IFN response varied from
2–4% (data not shown). Three of the repertoires derive
from tetramer-staining cells (columns A, C, and D) and
one from IFN captured cells (column B). The repertoires
in column B (IFN) and column C (tetramer) derive from
PBMC isolated on the same day. Once again, the IFN
and tetramer repertoires were very similar (73% of tet-
ramer-derived sequences appeared in the IFN-derived
repertoire). Because a TCR is a heterodimer made up of
an - and -chain, we also tested whether the IFN and
tetramer staining populations used similar TCR chains
(Table 4). Again, a strong correlation between repertoires
was observed (74% of tetramer-derived TCR sequences
appear in the IFN-derived repertoire).
A detailed analysis of TCR repertoire evolution during
the first year of EBV infection
Because the analysis on subject E3 began when he
presented with acute infectious mononucleosis, this al-
lowed for a comprehensive analysis of TCR repertoire as
acute EBV infection shifted into chronicity. During the first
3 weeks that E3 was infected, while the number of
HLA-A2/GL9 tetramer staining cells remained high (be-
TABLE 2
Subject E2 GL9-Specific TCR Repertoire
Column: A B
Time (weeks): 0 0
Method of isolation: IFNa Tet.b
Gene
usage




V J V D-region J % %
2.1 1.2 CSAR DSTGN GYT 4 4
2.1 1.2 CSAR DGTGN GYT — 2
2.1 1.3 CSAR DRTG NTI 6 14
2.1 1.3 CSAR DRGL GNT 28 20
2.1 1.3 CSAR DRAY GNT 1 —
2.1 1.3 CSAR DRSL GNT — 2
4.1 1.4 CSV GAAG TNE 6 8
6.2 2.4 CASSL AAGLNL KNI 3 —
7.3 2.1 CASSQ AGLAAYN EQF 1 2
7.3 2.1 CASSQ DGAGGLG EQF 3 —
12.2 2.6 CAIS GEFG SGA 5 —
12.3 2.5 CAS GGGGF QET 4 10
16.1 1.1 CASSQ SPGGI AFF 24 36
21.3 2.3 CASS YSSGK TDT 3 —
Other single sequences: 14 2
Total sequenced: 79 50
a Denotes TCR repertoire of T cells isolated by the INF capture
assay.
b Denotes TCR repertoire of T cells isolated based upon MHC class
I tetramer staining.
FIG. 2. V and MHC class I tetramer staining of EBV GL9 specific
CD8 T cells. Staining of PBMC with the HLA-A2/GL9 tetramer (y-axis)
and various V antibodies (x-axis). V staining from left to right: V1,
V2, V8, V16, V17, and V22, for subject: E1 (top row), E2 (middle
row), E3 (bottom row). The percentage of CD8 T cells that stained
positive with the MHC class I tetramer was as follows: E1, 0.8%; E2,
6.2%; and E3, 6.4%. Shown in the upper right-hand quadrant of each plot
is the percentage of MHC tetramer-positive cells that stain positive for
a particular V. Above each plot is the percentage of all the TCR
RT-PCR sequences by MHC tetramer staining and the IFN capture
assay that were of a particular V type. For example, in the top left-hand
plot, for subject E1, 16% of the tetramer-positive cells were V1 by flow
cytometry, while 31% of his PCR sequences were V1. The TCR se-
quence V distributions are based upon, for subject E1, TCR se-
quences in Table 1; for E2, TCR sequences in Table 2; for E3, TCR
sequences in Table 3, A–D.
476 COHEN ET AL.
tween 4 and 10%), no dramatic shifts in repertoire were
observed (Table 3, columns A–D). However, between
weeks 21 and 65 (columns E–H), as the tetramer-positive
population declined to 0.5% (data not shown), there was
a dramatic decline in frequency of a previously abundant
sequence: V22.1–J2.2-KGSVAP. Notably, this sequence
was absent from Week 21 and 48 repertoires (columns E
and G) and the GL9-specific cell lines grown during
Week 21 and 65 (columns F and H). Therefore, the ab-
sence of this sequence from later time points represents
a significant evolution in the repertoire.
In contrast to the decline of the V22.1–J2.2-KGSVAP
clone, it is harder to discern if smaller fluctuations in the
repertoire of Table 3 are significant. To evaluate the
extent experimental factors might contribute to repertoire
variability, the following experiments were performed.
HLA-A2/GL9 tetramer staining CD8 T cells from subject
E3 were isolated during Week 3 and grown in culture for
12 days (without further stimulation but in the presence
of IL-2). On Day 12, greater than 90% of the cultured T
cells stained positive with the HLA-A2/GL9 tetramer
(data not shown) and the repertoire of the cell line was
analyzed. Three independent PCR reactions were done
for the analysis: one reaction used RNA from 15,000
cells, and two PCR reactions used RNA from 150,000
cells. The 15,000 cell preparation was sequenced in two
groups (Table 5, columns A and B). Thus, four repertoires
were obtained from this cell line (Table 5, columns A–D),
which allowed for an evaluation of TCR repertoire vari-
ability stemming from (1) the limited number of TCR
sequenced (compare columns A and B; both derive from
15,000 cells and the same PCR reaction); (2) from PCR
variability (compare columns C and D; both derive from
150,000 cells but independent PCR reactions); and (3)
from PCR reactions derived from 15,000 vs 150,000 cells
(compare columns E and F; column E is a composite of
TABLE 3
Subject E3 GL9-Specific TCR Repertoire
Column:
Time (weeks)b:

























V J V D-region J % % % % % % % %
22.1* 2.2 CASS PGLTYP GEL 32 25 17 24 4 8 10 9
22.1 2.2 CASS KGSVAP GEL 14 19 10 9 — — — —
22.1* 2.2 CASS EGQVSP GEL 16 17 29 42 18 16 32 15
22.1 2.3 CASS EREEGMSL FGP — — — — 4 — — —
1.1 2.2 CASS SGLLS NTG — — 2 2 4 5 3 13
1.1 2.2 CASSV EGLRV TGE — — 2 4 — 5 — —
1.1 2.3 CASSV AQLAGGA DTQ — — — — 2 — — —
1.1* 2.3 CASSV GELAGGI DTQ — 8 — — — 14 — —
1.1 2.3 CASSV AELAGG TDT — — — — — 3 — —
2.1* 1.2 CSAR DGTGN GYT — — 2 — — 3 — 13
2.1 1.2 CSAR DETGN GYT — — — — 2 — — —
2.1 1.3 CSAR DRV GNT 14 4 5 4 — 3 5 —
2.1 2.1 CSA MAGGLRI YNE 5 — — — 4 — — —
3.1 2.1 CASS LRNSY EQF — — 5 2 10 3 5 1
4.1* 1.4 CS VGTGG TNE 2 8 2 2 24 19 — 25
4.1* 1.4 CS VGSEG TNE — — — — — 11 7 —
4.1 2.1 CS VEGATS EQF — — — — 4 — — —
4.1 2.3 CSV RGEG DTQ — — — — — — — 10
6.4 2.5 CASS PEQGY QET — — — — — — 5 —
6.5 2.3 CASSL RIDG TDT — 4 — — — — 4 —
7.1 2.1 CAS NPGTS NEQ — — — — — — — 10
13.6 1.3 CASS QGSELMT GNT — — — — 6 — — —
14.1 1.2 CASSL TGTFR GYT — — 2 2 — — — 3
16.1 2.1 CASSQ SPGGY QFF — — — — — — 4 —
16.1 2.5 CASSQ SPGG TQY 9 — — 2 — 3 — 3
18.1 2.1 CASSP PSGSGF NEQ — — 5 — — — — —
21.3 2.3 CASS FSSGT TDT — 8 10 — — — — —
Other minor sequencesc: 8 6 7 4 18 8 25 0
Total sequenced: 44 48 41 45 50 37 73 80
a Denotes TCR repertoire of MHC class I tetramer cells that were isolated and then expanded in culture for 10–14 days prior to repertoire analysis.
All other columns depict repertoires derived from cells immediately after MHC tetramer or IFN isolation.
b “Time” is defined from the date of onset of the symptoms of acute infectious mononucleosis.
c Denotes sequence that appeared in the TCR repertoire one or two times.
* Denotes a TCR sequence that corresponds to the TCR sequence of a limiting dilution clone isolated during week 21.
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columns A and B; column F is a composite of column C
and D). Although there was variability among these rep-
ertoires, when the TCR sequences were summed (col-
umn G), any sequence that appeared in greater than 3%
of the total sequences also appeared in at least three of
four of the original repertoires (columns A–D). These
results suggest that the RT-PCR repertoire method is
reproducible and given the number of TCR sequenced
for each repertoire (approximately 40–100 sequences
per repertoire) semiquantitative. Sequences isolated
from the GL9-specific cell line (column G) were also in
good agreement with TCR sequences derived from live
cell sorting (Tables 3 A–D; the composite is shown in
Table 5, column H).
Several other experiments confirmed that the TCR se-
quences listed in Tables 1–5 were representative of the
in vivo GL9-specific T cell repertoire. First, similar to
results previously described for subject E1, the TCR rep-
ertoire V distribution for subjects E2 and E3 were in
good agreement with the V distribution of tetramer-
stained cells identified by flow cytometry (Fig. 2). Second,
for subject E3, all TCR sequences derived from Week 21
GL9-specific limiting dilution clones correspond to se-
quences found in Table 3 (clone sequences are denoted
with an asterisk in Table 3) and all clones were able to
specifically lyse GL9-pulsed target cells (data not
shown). Third, V gene usage in Tables 1–3 agrees with
previous reports on V usage by GL9-specific CD8 T
cells (Annels et al., 2000; Lim et al., 2000). Last, for
subject E2, when repertoire analysis was done on bulk-
sorted CD8 T cells, of the 89 TCR sequences derived, 5
of the 89 sequences (5.6%) correspond to previously
derived GL9-specific sequences (data not shown). This
was in good agreement with MHC class I tetramer stain-
ing, where 6% of bulk CD8 T cells are GL9-specific (Fig.
2, see legend). As expected, the diversity of TCR se-
quences found in bulk CD8 T cells greatly exceeded
that of GL9-specific cells (data not show). In summary,
these data indicate that RT-PCR TCR analysis reproduc-
ibly describes TCR repertoire. Moreover, although in
general the EBV GL9-specific TCR repertoire was stable
during the first year of acute EBV infection, the loss of
TCR sequence, V22.1–J2.2-KGSVAP, demonstrates
repertoire evolution occurs as EBV infection progresses
from acute to chronic phase.
TCR repertoire analysis of CD8 T cells specific for
HIV immunodominant epitopes
A single T cell receptor is capable of recognizing many
different MHC-restricted peptides (Mason, 1998; Selin et
al., 1999). To assess prevalence of cross-reactive T cells,
and as a further test of the specificity of the IFN cap-
ture/TCR repertoire approach, we analyzed TCR reper-
toires in individuals having two immunodominant CD8 T
cell responses restricted by the same HLA allele. For this
study, TCR repertoire analysis was performed on two
HIV-positive subjects identified during acute HIV infec-
tion (Rosenberg et al., 2000), designated AC05 and AC16.
Both of these individuals had T cell responses directed
against two previously described immunodominant HIV
epitopes restricted by HLA-B14 (Johnson et al., 1992;
Kalams et al., 1994; Harrer et al., 1996). One response
was directed against an HIV Env-derived peptide, Env
EL9 (ERYLKDQQL), and the other against an HIV Gag
peptide, Gag DA9 (DRFYKTLRA) (Altfeld et al., 2001). To
isolate T cells specific for these epitopes, we used the
IFN capture assay and magnetic bead purification. To
facilitate the analysis, captured cells were expanded in
culture for 10–14 days prior to repertoire analysis. These
cells were not purified by FACS because we do not sort
HIV-infected samples at our facility.
Table 6 lists the TCR repertoire of patient AC05 and
AC16 for the DA9 and EL9 HLA-B14 restricted epitopes.
Despite the same HLA class I restriction, we saw no TCR
sequences that recognize both epitopes. Furthermore,
when the cell lines were tested for cytolytic activity or
restimulated for IFN production, the lines were highly
specific for the antigen against which they were raised
(e.g., greater than 80% of T cells secreted IFN upon
TABLE 4
Subject E3 GL9 Specific TCR Repertoire
Column:
Time (weeks):







V J V Joining-region J % %
1.4 1.3 CAV AAGNDY KLS — 4
1.5 17.9 CVV SGYLTT* KLT 10 —
2.3 9.10 CVVN PRDSGY ALN 19 28
2.3 16.5 CVVN GGDSSY KLI 7 14
2.3 16.5 CVVN GKDSSY KLI 6 2
4.1 1.8 CI LLRDSNY QLI — 2
4.1 10.1 CI LDNAGNNR KLI — 2
12.1 10.1 CA LVNAGNNR KLI 3 2
15.1 3.2 CAE DRSA RLM 12 5
15.1 3.2 CAE DNNA RLM 1 2
15.1 9.14 CAE VSFLPGNT PLV — 2
15.1 9.14 CAE SPFSGNT PLV 1 —
15.1 9.7 CAE QSAD GLT 4 —
15.1 14.1 CAE STG KLI 16 7
15.1 14.1 CAE IESNTG KLI 1 2
15.1 16.1 CA VYSSAS KII 1 4
20.1 17.5 C PDQTGAN NLF 4 —
21.1 9.11 CAA GGSQG NLI 1 2
23.1 17.11 CA VAHYGGATN KLI — 5
29.1 1.3 CG TERRSDY KLS 4 7
30.1 9.10 CA VGNSGY ALN — 2
Other single sequences: 6 11
Total sequenced: 68 57
a Due to space considerations only a portion of the D region
sequence of this TCR is shown in the table. The full D sequence is
SGYLTTSSALEPTLTGGGN.
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peptide stimulation) but did not recognize the alternative
HLA-B14-restricted epitope (data not shown). Thus, a
mutually exclusive set of T cells recognize these
epitopes. This further demonstrates that the IFN cap-
ture assay identifies discrete CD8 T cell populations.
Strikingly, in both subjects, a high percentage of TCR
that recognize the Env EL9 epitope had D regions
containing the amino acid sequence GQG, QG, or GQ.
The frequency of this motif was as follows: subject AC05,
95% (105 of 110 TCR sequences); AC16, 77% (34 of 44
TCR sequences); and in a third subject, AC13 (data not
shown), 83% (39 of 47 TCR sequences).
DISCUSSION
Here we used MHC class I tetramer staining (Altman
et al., 1996) and an IFN capture assay (Manz et al., 1995;
Brosterhus et al., 1999) to isolate virus-specific T cells for
TCR repertoire analysis. While this work was in progress,
a similar approach for repertoire analysis using IFN
capture (Douek et al., 2002) and tetramer staining (Chen
et al., 2001) were reported. Intracellular cytokine staining
(ICS) (Picker et al., 1995), an alternative approach for
isolating IFN-producing cells, was not utilized because
it requires chemical fixation of cells prior to IFN stain-
ing. Fixation modifies cellular RNA, making it difficult to
use the RNA for RT-PCR (Masuda et al., 1999). In con-
trast, cells isolated by the IFN-capture technique are
viable, and their RNA are intact. Because whole proteins
can also be used to stimulate T cells for IFN capture
isolation, this methodology allows for repertoire analysis
even when the optimal peptide epitope or MHC restric-
tion have not been defined. This is particularly valuable
for CD4 T cell repertoire analysis (T. O. Cameron, manu-
script in preparation), where few MHC class II tetramer
reagents currently exist.
In contrast to other techniques frequently used for
TABLE 5
Subject E3 GL9 Specific TCR Repertoire Control Experiment
V J V D-region J Aa Ba Cb Db Ec Fc Gd Hd
22.1 2.2 CASS PGLTYP GEL 33% 31% 15% 33% 32% 24% 27% 25%
22.1 2.2 CASS KGSVAP GEL 7% 5% 5% 2% 6% 3% 4% 13%
22.1 2.2 CASS EGQVSP GEL 14% 11% 11% 14% 12% 13% 13% 26%
1.1 2.1 CASSV VGSD EQF — 2% — — 1% — 0.5% —
1.1 2.2 CASS SGLLS NTG 7% 5% 11% 6% 6% 9% 8% 2%
1.1 2.2 CASSV EGLRV TGE 2% — — — 1% — 0.5% 2%
1.1 2.3 CASSV GELAGGI DTQ — 5% 6% 3% 3% 5% 4% 2%
1.1 2.3 CASSV AELAGG TDT — 2% — — 1% — 0.5% —
2.1 1.2 CSAR DGTGN GYT — 2% 3% 2% 1% 2% 2% 0.5%
2.1 1.3 CSAR DRV GNT 5% — 8% 6% 2% 7% 5% 7%
2.1 2.1 CSA MAGGLRI YNE — 4% — — 2% — 1% 1%
3.1 2.1 CASS LRNSY EQF 7% 7% 2% 6% 7% 4% 5% 2%
4.1 1.4 CS VGTGG TNE 5% 2% 6% 10% 3% 8% 6% 4%
4.1 1.4 CS VGSEG TNE 5% 5% 15% 3% 5% 9% 7% —
4.1 1.4 CS AGTGG TNE — 4% — — 2% — 1% —
4.1 2.1 CS VAGLTTI EQF — 2% — — 1% — 0.5% 0.5%
4.1 2.1 CSV EAGGSI YNE — 4% — — 2% — 1% —
4.1 2.1 CSV EAGGRI YNE 2% — — 2% 1% 1% 1% —
6.4 1.1 CASSL DVG TEA 2% — — — 1% — 0.5% —
6.4 2.1 CASS LDAGD EQF — — 2% 2% — 2% 1% —
6.5 2.3 CASSL RIDG TDT — — — — — — — 1%
8.2 2.5 CASS FGQ QET — 2% 2% — 1% 1% 1% 1%
14.1 1.2 CASSL TGTFR GYT — — 5% 2% — 3% 2% 1%
16.1 2.1 CASSQ SPGGY QFF — — — 2% — 1% 0.5% —
16.1 2.5 CASSQ SPGG TQY — 2% — 2% 1% 1% 1% 3%
18.1 2.1 CASSP PSGSGF NEQ — — — — — — — 1%
21.3 2.3 CASS FSSGT TDT 9% — 3% 2% 4% 2% 3% 4%
Other minor sequences: 2% 5% 6% 5% 4% 6% 5% 6%
Total sequenced: 43 55 62 63 98 125 223 178
Note. All TCR repertoires depicted in this table (except column H, see below) were derived from tetramer positive cells isolated from subject E3
during week 3. These isolated cells were then expanded in culture for 12 days prior to repertoire analysis.
a The repertoires of columns A and B were derived from 15,000 cells.
b The repertoires of columns C and D were derived from 150,000 cells.
c The repertoire of column E was derived from 15,000 cells (col. A  B), while that of column F was derived from 150,000 cells (col. C  D).
d The repertoire of column G is a compilation of the cell line repertoires from Table 5, col. A–D, while the repertoire of column H is a compilation
of live sorted cell repertoires from Table 3, col. A–D.
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repertoire analysis (Diu et al., 1993; Pannetier et al., 1993;
Maslanka et al., 1995), the methodology described here
derives DNA sequences for the repertoire and therefore
provides information on repertoire clonality. The impor-
tance of this is demonstrated in Table 3, where the loss
of the TCR sequence, V22.1–J2.2-KGSVAP, over time
might have been missed by these alternative ap-
proaches because of the presence of other dominant
V22.1–J2.2 clones. TCR analysis of CTL clones derived
by limiting dilution cloning, similar to the methodology
described here, also determines TCR repertoire clonality,
but cloning cells is a labor-intensive approach and ex-
tended in vitro culture of T cells may allow selection bias
to skew the repertoire.
To establish the validity of the IFN capture technique
for TCR repertoire analysis, we compared the repertoire
of IFN-secreting T cells to MHC class I tetramer stain-
ing cells. In the three EBV-positive subjects studied the
frequency of IFN-secreting cells, using either the IFN
catch assay or the ICS, was generally two- to fourfold
lower than tetramer staining (data not shown). Because
the primary purpose of this analysis was to compare
IFN and MHC class I tetramer staining cell reper-
toires, we did not investigate further whether the differ-
TABLE 6
HIV-Specific T-Cell TCR Repertoires
Antigen: HIV Env EL9 Antigen: HIV Gag DA9
V J D-region % V J D-region %
Subject: AC05
1.1 2.1 GGQGRP 7a 14.1 2.7 FSALWD 66
1.1 2.1 GKQGAP 1a 14.1 1.1 SWDRQ 26
2.1 1.2 RGQGID 4a 14.1 1.1 SWDRR 1
4.1 1.2 VSLQG 4 14.1 1.1 SWGRQ 1
4.1 1.2 NTRQGS 2a 14.1 2.5 WSDGK 1
4.1 1.2 ESRQGS 1 Single sequences: 5
6.4 1.2 RAGQGD 5 Total sequenced: 98
6.4 2.1 SRQGVPQ 3
6.4 2.3 SRQGIP 3a
8.2 1.4 KGQGEA 1
8.2 2.1 KGQGSD 3a
8.2 2.7 KRSQGQGH 48
13.1 2.7 WGGQGDRK 2




2.1 1.2 GQGID 16 5.6 1.1 SDT 6
2.1 1.2 GQGVD 2 5.6 1.1 SET 2
2.1 1.2 GQGIE 2 6.3 1.1 LGDA 15
2.1 1.2 RGQGIP 7 6.3 2.3 SWGDP 2
2.1 1.2 GQGVF 2 12.3 2.1 NEGSRI 4
2.1 1.5 GQGILGS 2 14.1 1.4 FSGGG 22
2.1 2.2 APRQGR 7 14.1 2.1 VQGRRY 2
2.1 2.6 AKGQA 7 14.1 2.3 LGSS 11
8.2 1.3 KGQGAE 14 14.1 2.3 WGDP 13
8.2 1.3 KGQGAG 2 14.1 2.3 TQLGAS 4
8.2 2.2 RGGQGYL 2 14.1 2.3 SPGSS 2
14.1 2.7 YVQGR 11 14.1 2.3 GSSF 2
14.1 2.7 VQRR 7 14.1 2.5 GSSS 2
14.1 2.7 LVQGRA 2 14.1 2.7 WGSPPE 4
16.1 2.7 ETGKT 7 17.1 1.1 PTPW 4
Single sequences: 9 Single sequences: 8
Total sequenced: 44 Total sequenced: 54
Note. The TCR repertoires depicted in this table were derived from IFN cells isolated by the capture assay and then expanded in culture for
10–14 days prior to repertoire analysis.
a Denotes a TCR sequence also found in a limiting dilution clone.
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ence in IFN and tetramer staining frequency was sig-
nificant. Nevertheless, discordance between the abun-
dance of tetramer staining and IFN producing EBV-
specific T cells is consistent with previous studies (Tan
et al., 1999; Hislop et al., 2001). Despite this difference in
staining frequencies, there were no major differences
between the IFN and tetramer TCR repertoires (Tables
2–5) that explained the higher frequency of tetramer
staining cells.
The TCR repertoire of subject E3 was followed over
the first year of EBV infection (Table 3). During this year
his MHC class I tetramer response fell from 10 to
0.5%. However, during this same period the majority of
TCR sequences seen at the end of the year corresponds
to sequences seen during the initial 3 weeks of EBV
infection (Tables 3 and 5). In a previous study on TCR
evolution during EBV infection, which also focused on
the EBV GL9 epitope (Annels et al., 2000), a greater
degree of repertoire evolution was reported than seen
here. Experimental design may account for some of
these differences as the previous study was based on
TCR repertoire analysis of T cell limiting dilution clones
and a more limited number of TCR sequences and rep-
ertoires. However, the results described here need to be
expanded to more patients, different EBV epitopes, and
chronologically later time points before we can general-
ize on the degree of TCR evolution that occurs during
EBV infection.
The most dramatic indication of repertoire evolution in
subject E3 during the first year of EBV infection was a
decrease in frequency in the TCR sequence V22.1–
J2.2-KGSVAP (Table 3). This TCR sequence appeared in
all five acute EBV infection TCR repertoires, weeks 1–3,
and 32 of 401 (8%) TCR sequences (Table 3, A–D, and
Table 5) and was the third most frequent TCR sequence
in the acute TCR repertoire, but disappeared from four
later chronic repertoires, weeks 21–65, and 0 of 240 (0%)
TCR sequences (Table 3, E–H; chi-square P value 
0.0001). Whether the decline in frequency of this TCR is
permanent and represents the loss of T cells bearing a
low affinity TCR (McHeyzer-Williams and Davis, 1995;
Busch and Pamer, 1999), T cell exhaustion (Moskophidis
et al., 1993), T cell dysfunction (Zajac et al., 1998), or
whether it represents a temporary or random fluctuation
in the TCR repertoire, is not clear. Temporary, cyclical
fluctuations in the TCR repertoire were reported during
SIV infection in rhesus macaques (Chen et al., 2001) and
during HIV infection (S. A. Islam and S. A. Kalams, un-
published results).
In addition to characterizing the TCR during EBV in-
fection, we used surface capture of IFN to characterize
the TCR repertoire during HIV infection. Most HIV-in-
fected HLA-B14 individuals develop an immunodomi-
nant response toward the HIV Env EL9 epitope during
acute HIV infection (Altfeld et al., 2001). In the three
HLA-B14 subjects studied, the EL9-specific T cell popu-
lation was polyclonal yet contained a highly conserved
D region amino acid motif: GQG, GQ, or QG (Table 6
and data not shown). In the germline D region there are
two D sequences, D1 and D2. The D1 germline
DNA sequence, GGGACAGGGGGC, in its second read-
ing frame, encodes for amino acids GQG. In crystal
structures of TCR/MHC/peptide complexes the D re-
gion directly contacts the central portion of the antigenic
peptide (Garboczi and Biddison, 1999). We speculate that
for the HIV Env EL9 peptide, recognition by a TCR de-
pends critically on the presence of the GQG motif and
less critically on nucleotide bases added or deleted at
V(D)J splice junctures during N-diversification. Because
GQG is encoded in the germline D1 gene, it is likely
that a high frequency of naive T cells contain this motif
prior to HIV infection (indeed, when bulk CD8 T cells
from two HIV-seronegative subjects were sequenced,
5% of the circulating CD8 T cells contained the motif;
data not shown). In contrast, TCR sequences created by
N-diversification should exist in the naive T cell popula-
tion at much lower frequencies because N-diversification
is a random process and unlikely to generate many T
cells bearing the same unique amino acid sequence.
The high naive precursor frequency of T cells specific for
the Env EL9 epitope may account for why the epitope is
so frequently targeted early in HIV infection. Therefore,
although many factors may determine epitope domi-
nance (Selin et al., 1999; Yewdell and Bennink, 1999), our
work suggests that T cell precursor frequency underlies
the frequent targeting of the EL9 epitope in early HIV
infection.
In summary, we find no evidence for differential TCR
usage among EBV-specific MHC class I tetramer-posi-
tive T cells and those that secrete IFN. Moreover, only
a modest amount of TCR repertoire evolution was seen
during the first year of EBV infection. For HIV infection we
suggest that naive T cell precursor frequency influences
the epitopes targeted during acute HIV infection.
MATERIALS AND METHODS
Subjects
Three healthy HLA-A2.01 positive, EBV-infected sub-
jects were identified based on HLA typing and staining
with the HLA-A2/GL9 tetramer. GL9 is a nine amino acid
epitope, GLCTLVAML, derived from the EBV lytic protein
BMLF1 (residues 280–288). Subjects E1 and E2 were in
the chronic phase of EBV infection. Subject E3 was
identified with acute infectious mononucleosis based
upon clinical evaluation and supporting diagnostic stud-
ies.
Two HIV-positive subjects, AC05 and AC16, from a
previously described cohort were selected for this study
(Rosenberg et al., 2000). Briefly, the cohort contained
subjects identified during symptomatic acute HIV infec-
tion and subsequently started on a regimen of highly
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active anti-retroviral therapy with periodic supervised
treatment interruptions.
INF capture assay
PBMC were isolated from 20–90 mL whole blood by
Ficoll–Paque (Pharmacia, San Diego, CA). Initial experi-
ments indicated that freezing PBMC did not alter the
recovery of INF CD8 T cells (data not shown). There-
fore, both fresh and frozen PBMC were used in the INF
capture assay. PBMC in culture were stimulated with
peptides at 1–4 g/ml, augmented with 1 g/ml anti-
CD28 and anti-CD49d antibodies (BD Biosciences, San
Jose, CA). After 6–9 h at 37°C in 5% CO2 the INF capture
assay (Manz et al., 1995; Brosterhus et al., 1999) was
performed and INF-secreting cells were magnetically
sorted following the manufacturer’s protocol (Miltenyi
Biotec, Auburn, CA). IFN-secreting cells were further
purified by FACS, except where noted otherwise, gating
on CD3, CD8, IFN cells and excluding dead cells
based on light scatter and uptake of 7-aminoactinomycin
(7AAD) (Schmid et al., 1994).
Generation of T cell lines
All antigen-specific T cell lines described in this article
were purified from PBMC using either the INF capture
assay and magnetic bead sorting or the MHC class I
tetramer staining and FACS. Sorted cells were resus-
pended in media containing 2  106/ml irradiated heter-
ologous feeder cells. IL-2 (50 units/ml) was added on
Day 4 and thereafter cells were fed IL-2 containing media
every 2–3 days. By Day 10–14 most irradiated feeder
cells had died. The remaining cells were tested for an-
tigen specificity by intracellular cytokine staining or by
MHC class I tetramer staining. Cell lines where 80% of
T cells stained for either tetramer or INF were used for
TCR analysis. Where indicated, clones were made from
the cell lines as described (Walker et al., 1987; Islam et
al., 2001).
T cell repertoire analysis
RNA was extracted from T cells using STAT-60 (Tel-
Test B, Friendswood, TX). Reverse transcription (RT) was
performed with Superscript II (Invitrogen, Carlsbad, CA)
and primed with either a TCR RT oligomer: 5 AATC-
CTTTCTCTTGACCATG 3 or a TCR oligomer: 5 AT-
CATAAATTCGGGTAGGATCC 3. Prior to PCR a 5 anchor
primer was attached to the 5 end of TCR cDNA which
allowed for the PCR of all TCR sequences with a single
PCR primer pair. The 5 anchor primer was attached
either with the Marathon or SMART RACE cDNA Ampli-
fication kit (Clontech, Palo Alto, CA). However, when the
number of input cells was low (50,000 cells), we had
more reproducible results amplifying TCR DNA using the
SMART system. Therefore, all anchor RT-PCR reactions
were performed using the SMART system (except for
Table 1, column A, where the Marathon system was
used).
PCR followed the manufacturer’s SMART PCR protocol.
For TCR the 3 constant region PCR primer was 5 TT-
GGGTGTGGGAGATCTCTGCTTCTGATGGC 3. For TCR,
one of the following 3 primers were used: 5 ATCGGT-
GAATAGGCAGACAGACTTGTCAC, GGCAGACAGACTTGT-
CACTGGATTTAGAG, and CAGCACTGTTGCTCTTGAAGTC-
CATAG 3. The 5 PCR primer is supplied with the SMART
kit. At least two separate PCR reactions were carried out for
each TCR repertoire to minimize PCR artifacts. PCR prod-
ucts were gel purified and cloned using the TOPO TA
cloning kit (Invitrogen).
MHC class I tetramers
MHC tetramers were provided by Coulter (Miami, FL)
or prepared as described (Altman et al., 1996). Tetramer
staining of PBMC was done at 37°C for 30 in PBS/1%
FCS. Cells were then placed on ice and stained with the
following antibodies for 30: CD3-PerCP, CD8-APC (BD
Biosciences), and where indicated, one of various V-
FITC antibodies (V1, V2, V5.1, V7, V8, V11, V12,
V13.1, V13.6, V14, V16, V17, V20, V21.3, V22
(Coulter)).
Intracellular cytokine staining
ICS was done as described (Picker et al., 1995) except
that the cells were fixed and permeabilized using the Fix
& Perm Kit (Caltag, Burlingame, CA). Following perme-
abilization, staining for cell-surface molecules was done
concurrent with intracellular IFN staining (INF-FITC,
BD Biosciences).
51Chromium release killing assay
51Cr release killing assays were performed using T cell
lines and peptide pulsed B cell lines as described (Islam
et al., 2001).
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